Future studies such as single-cell RNA sequencing, spatial transcriptomics, or quantitative immunofluorescence may further define the immune cell composition and localization in CCNE1-amplified gastric cancer, and how the distinct tumor microenvironment may impact response to therapy. The gene discussed is CCNE1; the disease is neoplasm.